Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 85

1.

Revised criteria for diagnosis of NIFTP reveals a better correlation with tumor biological behavior.

Paniza ACJ, Mendes TB, Vianna MDB, Thomaz DMD, Chiappini P, Colazza-Gama GA, Lindsey SC, de Carvalho MB, Alves VAF, Curione O, Bastos AU, Cerutti JM.

Endocr Connect. 2019 Oct 1. pii: EC-19-0459. doi: 10.1530/EC-19-0459. [Epub ahead of print]

2.

Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma.

Bim LV, Navarro FCP, Valente FOF, Lima-Junior JV, Delcelo R, Dias-da-Silva MR, Maciel RMB, Galante PAF, Cerutti JM.

BMC Med Genomics. 2019 Jul 9;12(1):104. doi: 10.1186/s12920-019-0552-1.

3.

Ginkgo biloba treatments reverse the impairment of conditioned suppression acquisition induced by GluN2B-NMDA and 5-HT1A receptor blockade: Modulatory effects of the circuitry of the dorsal hippocampal formation.

Zamberlam CR, Tilger MAS, Moraes L, Cerutti JM, Cerutti SM.

Physiol Behav. 2019 Oct 1;209:112534. doi: 10.1016/j.physbeh.2019.04.023. Epub 2019 May 6.

PMID:
31071338
4.

Molecular Study of Thyroid Cancer in World Trade Center Responders.

van Gerwen MAG, Tuminello S, Riggins GJ, Mendes TB, Donovan M, Benn EKT, Genden E, Cerutti JM, Taioli E.

Int J Environ Res Public Health. 2019 May 7;16(9). pii: E1600. doi: 10.3390/ijerph16091600.

5.

AGK-BRAF is associated with distant metastasis and younger age in pediatric papillary thyroid carcinoma.

Sisdelli L, Cordioli MICV, Vaisman F, Moraes L, Colozza-Gama GA, Alves PAG Jr, Araújo ML Jr, Alves MTS, Monte O, Longui CA, Cury AN, Carvalheira G, Cerutti JM.

Pediatr Blood Cancer. 2019 Jul;66(7):e27707. doi: 10.1002/pbc.27707. Epub 2019 Mar 29.

PMID:
30924609
6.

Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study.

Maciel RMB, Camacho CP, Assumpção LVM, Bufalo NE, Carvalho AL, de Carvalho GA, Castroneves LA, de Castro FM Jr, Ceolin L, Cerutti JM, Corbo R, Ferraz TMBL, Ferreira CV, França MIC, Galvão HCR, Germano-Neto F, Graf H, Jorge AAL, Kunii IS, Lauria MW, Leal VLG, Lindsey SC, Lourenço DM Jr, Maciel LMZ, Magalhães PKR, Martins JRM, Martins-Costa MC, Mazeto GMFS, Impellizzeri AI, Nogueira CR, Palmero EI, Pessoa CHCN, Prada B, Siqueira DR, Sousa MSA, Toledo RA, Valente FOF, Vaisman F, Ward LS, Weber SS, Weiss RV, Yang JH, Dias-da-Silva MR, Hoff AO, Toledo SPA, Maia AL.

Endocr Connect. 2019 Mar 1;8(3):289-298. doi: 10.1530/EC-18-0506.

7.

HOPX homeobox methylation in differentiated thyroid cancer and its clinical relevance.

Lima EU, Rubio IGS, Silva JC Jr, Galrão AL, Pêssoa DP, Oliveira TLC, Carrijo F, Silva IC, Fonseca LE, Sampaio LJL, Lima CRA, Cerutti JM, Ramos HE.

Endocr Connect. 2018 Oct 1. pii: EC-18-0380.R2. doi: 10.1530/EC-18-0380. [Epub ahead of print]

8.

FAM129A regulates autophagy in thyroid carcinomas in an oncogene-dependent manner.

Nozima BH, Mendes TB, Pereira GJDS, Araldi RP, Iwamura ESM, Smaili SS, Carvalheira GMG, Cerutti JM.

Endocr Relat Cancer. 2019 Jan 1;26(1):227-238. doi: 10.1530/ERC-17-0530.

PMID:
30400008
9.

The human papillomavirus (HPV)-related cancer biology: An overview.

Araldi RP, Sant'Ana TA, Módolo DG, de Melo TC, Spadacci-Morena DD, de Cassia Stocco R, Cerutti JM, de Souza EB.

Biomed Pharmacother. 2018 Oct;106:1537-1556. doi: 10.1016/j.biopha.2018.06.149. Epub 2018 Jul 26. Review.

PMID:
30119229
10.

Penetrance of phaeochromocytoma in RET G533C carriers differs between South America and Europe.

Maciel RMB, Bim LV, Camacho CP, Cerutti JM.

Endocr Relat Cancer. 2018 Sep;25(9):L49-L51. doi: 10.1530/ERC-17-0349. No abstract available.

PMID:
30012587
11.

Flavones-bound in benzodiazepine site on GABAA receptor: Concomitant anxiolytic-like and cognitive-enhancing effects produced by Isovitexin and 6-C-glycoside-Diosmetin.

Oliveira DR, Todo AH, Rêgo GM, Cerutti JM, Cavalheiro AJ, Rando DGG, Cerutti SM.

Eur J Pharmacol. 2018 Jul 15;831:77-86. doi: 10.1016/j.ejphar.2018.05.004. Epub 2018 May 5.

PMID:
29738701
12.

LIMD2 Is Overexpressed in BRAF V600E-Positive Papillary Thyroid Carcinomas and Matched Lymph Node Metastases.

Pinheiro Dos Santos MJC, Bastos AU, da Costa VR, Delcelo R, Lindsey SC, Colozza-Gama GA, Peng H, Rauscher FJ 3rd, Oler G, Cerutti JM.

Endocr Pathol. 2018 Sep;29(3):222-230. doi: 10.1007/s12022-018-9526-7.

PMID:
29560564
13.

ETV6-NTRK3 and STRN-ALK kinase fusions are recurrent events in papillary thyroid cancer of adult population.

Bastos AU, de Jesus AC, Cerutti JM.

Eur J Endocrinol. 2018 Jan;178(1):83-91. doi: 10.1530/EJE-17-0499. Epub 2017 Oct 18.

PMID:
29046324
14.

ABI3, a component of the WAVE2 complex, is potentially regulated by PI3K/AKT pathway.

Moraes L, Zanchin NIT, Cerutti JM.

Oncotarget. 2017 Jun 29;8(40):67769-67781. doi: 10.18632/oncotarget.18840. eCollection 2017 Sep 15.

15.

The G534E variant in HABP2 is not associated with increased risk of familial nonmedullary thyroid cancer in Brazilian Kindreds.

de Mello LEB, Araujo AN, Alves CX, de Paiva FJP, Brandão-Neto J, Cerutti JM.

Clin Endocrinol (Oxf). 2017 Jul;87(1):113-114. doi: 10.1111/cen.13352. Epub 2017 May 11. No abstract available.

PMID:
28418605
16.

Evidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2A.

Cunha LL, Lindsey SC, França MIC, Sarika L, Papathoma A, Kunii IS, Cerutti JM, Dias-da-Silva MR, Alevizaki M, Maciel RMB.

Eur J Endocrinol. 2017 May;176(5):515-519. doi: 10.1530/EJE-16-1021. Epub 2017 Jan 30.

PMID:
28137737
17.

Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children.

Cordioli MI, Moraes L, Bastos AU, Besson P, Alves MT, Delcelo R, Monte O, Longui C, Cury AN, Cerutti JM.

Thyroid. 2017 Feb;27(2):182-188. doi: 10.1089/thy.2016.0387. Epub 2016 Dec 27.

PMID:
27849443
18.

PVALB diminishes [Ca2+] and alters mitochondrial features in follicular thyroid carcinoma cells through AKT/GSK3β pathway.

Mendes TB, Nozima BH, Budu A, de Souza RB, Braga Catroxo MH, Delcelo R, Gazarini ML, Cerutti JM.

Endocr Relat Cancer. 2016 Sep;23(9):769-82. doi: 10.1530/ERC-16-0181. Epub 2016 Jul 25.

PMID:
27458244
19.

AGK-BRAF gene fusion is a recurrent event in sporadic pediatric thyroid carcinoma.

Cordioli MI, Moraes L, Carvalheira G, Sisdelli L, Alves MT, Delcelo R, Monte O, Longui CA, Cury AN, Cerutti JM.

Cancer Med. 2016 Jul;5(7):1535-41. doi: 10.1002/cam4.698. Epub 2016 Mar 31.

20.

Transcriptional regulation of the potential tumor suppressor ABI3 gene in thyroid carcinomas: interplay between methylation and NKX2-1 availability.

Moraes L, Galrão AL, Rubió I, Cerutti JM.

Oncotarget. 2016 May 3;7(18):25960-70. doi: 10.18632/oncotarget.8416.

21.

Thyroid-Specific Genes Expression Uncovered Age-Related Differences in Pediatric Thyroid Carcinomas.

Cordioli MI, Moraes L, Alves MT, Delcelo R, Monte O, Longui CA, Cury AN, Cerutti JM.

Int J Endocrinol. 2016;2016:1956740. doi: 10.1155/2016/1956740. Epub 2016 Feb 28.

22.

Effects of a Flavonoid-Rich Fraction on the Acquisition and Extinction of Fear Memory: Pharmacological and Molecular Approaches.

de Oliveira DR, Zamberlam CR, Rêgo GM, Cavalheiro A, Cerutti JM, Cerutti SM.

Front Behav Neurosci. 2016 Jan 5;9:345. doi: 10.3389/fnbeh.2015.00345. eCollection 2015.

23.

Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.

Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O'Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M.

J Clin Endocrinol Metab. 2016 Jan;101(1):264-74. doi: 10.1210/jc.2015-2917. Epub 2015 Nov 3.

24.

BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma.

Bastos AU, Oler G, Nozima BH, Moysés RA, Cerutti JM.

Eur J Endocrinol. 2015 Oct;173(4):525-40. doi: 10.1530/EJE-15-0254.

PMID:
26338373
25.

microRNA-106b-mediated down-regulation of C1orf24 expression induces apoptosis and suppresses invasion of thyroid cancer.

Carvalheira G, Nozima BH, Cerutti JM.

Oncotarget. 2015 Sep 29;6(29):28357-70. doi: 10.18632/oncotarget.4947.

26.

Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?

Cordioli MI, Moraes L, Cury AN, Cerutti JM.

Endocr Relat Cancer. 2015 Dec;22(6):R311-24. doi: 10.1530/ERC-15-0381. Epub 2015 Aug 25. Review.

PMID:
26307021
27.

RET Y791F Variant Does Not Increase the Risk for Medullary Thyroid Carcinoma.

Toledo RA, Maciel RM, Erlic Z, Lourenço DM Jr, Cerutti JM, Eng C, Neumann HP, Toledo SP.

Thyroid. 2015 Aug;25(8):973-4. doi: 10.1089/thy.2015.0168. Epub 2015 Jun 12. No abstract available.

PMID:
25950813
28.

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.

Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID, Luster M, Parisi MT, Rachmiel M, Thompson GB, Yamashita S; American Thyroid Association Guidelines Task Force.

Thyroid. 2015 Jul;25(7):716-59. doi: 10.1089/thy.2014.0460. Review.

29.

Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.

Barbieri RB, Bufalo NE, Secolin R, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Eur J Endocrinol. 2014 Dec;171(6):761-7. doi: 10.1530/EJE-14-0461.

PMID:
25565272
30.

Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.

Toledo RA, Hatakana R, Lourenço DM Jr, Lindsey SC, Camacho CP, Almeida M, Lima JV Jr, Sekiya T, Garralda E, Naslavsky MS, Yamamoto GL, Lazar M, Meirelles O, Sobreira TJ, Lebrao ML, Duarte YA, Blangero J, Zatz M, Cerutti JM, Maciel RM, Toledo SP.

Endocr Relat Cancer. 2015 Feb;22(1):65-76. doi: 10.1530/ERC-14-0491. Epub 2014 Nov 25.

31.

Flavones from Erythrina falcata are modulators of fear memory.

de Oliveira DR, Zamberlam CR, Gaiardo RB, Rêgo GM, Cerutti JM, Cavalheiro AJ, Cerutti SM.

BMC Complement Altern Med. 2014 Aug 5;14:288. doi: 10.1186/1472-6882-14-288.

32.

Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.

Araujo AN, Moraes L, França MI, Hakonarson H, Li J, Pellegrino R, Maciel RM, Cerutti JM.

J Clin Endocrinol Metab. 2014 Jun;99(6):E1104-12. doi: 10.1210/jc.2013-2993. Epub 2014 Mar 6.

PMID:
24601688
33.

Analysis of KIAA1549-BRAF fusion gene expression and IDH1/IDH2 mutations in low grade pediatric astrocytomas.

Cruz GR, Dias Oliveira I, Moraes L, Del Giudice Paniago M, de Seixas Alves MT, Capellano AM, Saba-Silva N, Cavalheiro S, Cerutti JM, Toledo SR.

J Neurooncol. 2014 Apr;117(2):235-42. doi: 10.1007/s11060-014-1398-1. Epub 2014 Feb 17.

PMID:
24532263
34.

Hypermethylation of a New Distal Sodium/Iodide Symporter (NIS) enhancer (NDE) is associated with reduced NIS expression in thyroid tumors.

Galrão AL, Camargo RY, Friguglietti CU, Moraes L, Cerutti JM, Serrano-Nascimento C, Suzuki MF, Medeiros-Neto G, Rubio IG.

J Clin Endocrinol Metab. 2014 Jun;99(6):E944-52. doi: 10.1210/jc.2013-1450. Epub 2014 Jan 16.

PMID:
24432988
35.

A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.

Signorini PS, França MI, Camacho CP, Lindsey SC, Valente FO, Kasamatsu TS, Machado AL, Salim CP, Delcelo R, Hoff AO, Cerutti JM, Dias-da-Silva MR, Maciel RM.

Clin Endocrinol (Oxf). 2014 Feb;80(2):235-45. doi: 10.1111/cen.12264. Epub 2013 Jun 28.

PMID:
23745650
36.

Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families.

Valente FO, Dias da Silva MR, Camacho CP, Kunii IS, Bastos AU, da Fonseca CC, Simião HP, Tamanaha R, Maciel RM, Cerutti JM.

J Endocrinol Invest. 2013 Dec;36(11):975-81. doi: 10.3275/8997. Epub 2013 May 30.

PMID:
23723040
37.

DDIT3, STT3A (ITM1), ARG2 and FAM129A (Niban, C1orf24) in diagnosing thyroid carcinoma: variables that may affect the performance of this antibody-based test and promise.

Carvalheira GM, Nozima BH, Riggins GJ, Cerutti JM.

Mod Pathol. 2013 Apr;26(4):611-3. doi: 10.1038/modpathol.2012.212. No abstract available.

38.

Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.

Santos JC, Bastos AU, Cerutti JM, Ribeiro ML.

BMC Cancer. 2013 Feb 15;13:79. doi: 10.1186/1471-2407-13-79.

39.

An unusual genotype-phenotype correlation in MEN 2 patients: should screening for RET double germline mutations be performed to avoid misleading diagnosis and treatment?

Cerutti JM, Maciel RM.

Clin Endocrinol (Oxf). 2013 Oct;79(4):591-2. doi: 10.1111/cen.12155. Epub 2013 May 11. No abstract available.

PMID:
23330657
40.

Optimizing nucleic acid extraction from thyroid fine-needle aspiration cells in stained slides, formalin-fixed/paraffin-embedded tissues, and long-term stored blood samples.

Kizys MM, Cardoso MG, Lindsey SC, Harada MY, Soares FA, Melo MC, Montoya MZ, Kasamatsu TS, Kunii IS, Giannocco G, Martins JR, Cerutti JM, Maciel RM, Dias-da-Silva MR.

Arq Bras Endocrinol Metabol. 2012 Dec;56(9):618-26.

PMID:
23329184
41.

Long-term treatment with standardized extract of Ginkgo biloba L. enhances the conditioned suppression of licking in rats by the modulation of neuronal and glial cell function in the dorsal hippocampus and central amygdala.

Oliveira DR, Sanada PF, Filho AC, Conceição GM, Cerutti JM, Cerutti SM.

Neuroscience. 2013 Apr 3;235:70-86. doi: 10.1016/j.neuroscience.2013.01.009. Epub 2013 Jan 12.

PMID:
23321541
42.

Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.

Barbieri RB, Bufalo NE, Cunha LL, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Clin Endocrinol (Oxf). 2013 Aug;79(2):288-93. doi: 10.1111/cen.12136. Erratum in: Clin Endocrinol (Oxf). 2013 Nov;79(5):750.

PMID:
23278115
43.

Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation tests.

Camacho CP, Lindsey SC, Melo MC, Yang JH, Germano-Neto F, Valente Fde O, Lima TR, Biscolla RP, Vieira JG, Cerutti JM, Dias-da-Silva MR, Maciel RM.

Thyroid. 2013 Mar;23(3):308-16. doi: 10.1089/thy.2012.0361.

44.

DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer.

Latini FR, Bastos AU, Arnoni CP, Muniz JG, Person RM, Baleotti W Jr, Barreto JA, Castilho L, Cerutti JM.

Blood Cells Mol Dis. 2013 Mar;50(3):161-5. doi: 10.1016/j.bcmd.2012.10.009. Epub 2012 Nov 17.

PMID:
23168236
45.

Employing genetic markers to improve diagnosis of thyroid tumor fine needle biopsy.

Cerutti JM.

Curr Genomics. 2011 Dec;12(8):589-96. doi: 10.2174/138920211798120781.

46.

Extended RET gene analysis in patients with apparently sporadic medullary thyroid cancer: clinical benefits and cost.

Lindsey SC, Kunii IS, Germano-Neto F, Sittoni MY, Camacho CP, Valente FO, Yang JH, Signorini PS, Delcelo R, Cerutti JM, Maciel RM, Dias-da-Silva MR.

Horm Cancer. 2012 Aug;3(4):181-6. doi: 10.1007/s12672-012-0109-7. Epub 2012 May 31.

PMID:
22648435
47.

Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.

Barbieri RB, Bufalo NE, Secolin R, Silva AC, Assumpção LV, Maciel RM, Cerutti JM, Ward LS.

Eur J Endocrinol. 2012 Feb;166(2):241-5. doi: 10.1530/EJE-11-0843. Epub 2011 Nov 2.

PMID:
22048975
48.

The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.

Oliveira MN, Hemerly JP, Bastos AU, Tamanaha R, Latini FR, Camacho CP, Impellizzeri A, Maciel RM, Cerutti JM.

Thyroid. 2011 Sep;21(9):975-85. doi: 10.1089/thy.2010.0190. Epub 2011 Aug 11.

PMID:
21834681
49.

ABI3 ectopic expression reduces in vitro and in vivo cell growth properties while inducing senescence.

Latini FR, Hemerly JP, Freitas BC, Oler G, Riggins GJ, Cerutti JM.

BMC Cancer. 2011 Jan 11;11:11. doi: 10.1186/1471-2407-11-11.

50.

PVALB, a new Hürthle adenoma diagnostic marker identified through gene expression.

Cerutti JM, Oler G, Delcelo R, Gerardt R, Michaluart P Jr, de Souza SJ, Galante PA, Huang P, Riggins GJ.

J Clin Endocrinol Metab. 2011 Jan;96(1):E151-60. doi: 10.1210/jc.2010-1318. Epub 2010 Oct 6.

Supplemental Content

Loading ...
Support Center